The Oxford handbook of the economics of the biopharmaceutical industry (Record no. 6967)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01502nam a2200313 a 4500 |
| 001 - CONTROL NUMBER | |
| control field | EDZ0000091967 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | StDuBDS |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240216142723.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m||||||||d|||||||| |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr|||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120704s2012 nyua fo| 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780199968749 (ebook) : |
| Terms of availability | No price |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | StDuBDS |
| Transcribing agency | StDuBDS |
| Description conventions | pn |
| 050 #0 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | HD9665.5 |
| Item number | .O94 2012 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 338.476157 |
| Edition number | 23 |
| 245 04 - TITLE STATEMENT | |
| Title | The Oxford handbook of the economics of the biopharmaceutical industry |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Patricia M. Danzon and Sean Nicholson. |
| 246 30 - VARYING FORM OF TITLE | |
| Title proper/short title | Economics of the biopharmaceutical industry |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | New York ; |
| -- | Oxford : |
| Name of publisher, distributor, etc. | Oxford University Press, |
| Date of publication, distribution, etc. | c2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (xix, 597 p.) : |
| Other physical details | ill. |
| 520 8# - SUMMARY, ETC. | |
| Summary, etc. | This examination of the economics of the biopharmaceutical industry has 18 chapters by health economists. Part 1 examines the economics of biopharmaceutical innovation. Part 2 examines the market for biopharmaceuticals with chapters on prices and reimbursement in industrialised and developing countries. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on print version record. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes bibliographical references and index. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmaceutical industry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biopharmaceutics |
| General subdivision | Economic aspects. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Danzon, Patricia Munch, |
| Dates associated with a name | 1946- |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nicholson, Sean. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version |
| International Standard Book Number | 9780199742998 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | Oxford handbooks online |
| Uniform Resource Identifier | <a href="http://dx.doi.org/10.1093/oxfordhb/9780199742998.001.0001">http://dx.doi.org/10.1093/oxfordhb/9780199742998.001.0001</a> |
No items available.